Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES
Document Type and Number:
Japanese Patent JP2019052154
Kind Code:
A
Abstract:
To provide a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative.SOLUTION: The present invention provides a pharmaceutical composition comprising a perillyl alcohol carbamate. The perillyl alcohol carbamate is conjugated with a chemotherapeutic agent.SELECTED DRAWING: Figure 1
More Like This:
Inventors:
THOMAS CHEN
DANIEL LEVIN
SATISH PUPALLI
DANIEL LEVIN
SATISH PUPALLI
Application Number:
JP2018206892A
Publication Date:
April 04, 2019
Filing Date:
November 01, 2018
Export Citation:
Assignee:
NEONC TECH INC
International Classes:
A61K31/4015; A61K31/4188; A61K31/635; A61P35/00; A61P35/02
Domestic Patent References:
| JP6431009B2 | 2018-11-28 | |||
| JP5797755B2 | 2015-10-21 | |||
| JP5982507B2 | 2016-08-31 |
Foreign References:
| WO2003057193A1 | 2003-07-17 | |||
| US20020177609A1 | 2002-11-28 | |||
| US20020137799A1 | 2002-09-26 | |||
| US20040192778A1 | 2004-09-30 | |||
| US4272441A | 1981-06-09 |
Other References:
KARDOSH: "MULTITARGET INHIBITION OF DRUG-RESISTANT MULTIPLE MYELOMA CELL LINES BY DIMETHYL-CELECOXIB(DMC),A NO", BLOOD [ONLINE], vol. V106 N13, JPN5013009918, 15 December 2005 (2005-12-15), pages 4330 - 4338, ISSN: 0004335988
GOLDHOFF: "TARGETED INHIBITION OF CYCLIC AMP PHOSPHODIESTERASE-4 PROMOTES BRAIN TUMOR REGRESSION", CLIN CANCER RES [ONLINE], vol. V14 N23, JPN5013009919, 1 December 2008 (2008-12-01), pages 7717 - 7725, ISSN: 0004335989
GOLDHOFF: "TARGETED INHIBITION OF CYCLIC AMP PHOSPHODIESTERASE-4 PROMOTES BRAIN TUMOR REGRESSION", CLIN CANCER RES [ONLINE], vol. V14 N23, JPN5013009919, 1 December 2008 (2008-12-01), pages 7717 - 7725, ISSN: 0004335989
Attorney, Agent or Firm:
Taro Yaguchi